Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2010

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

Placebo

Placebo comparator

BIOLOGICAL

CAD106

Trial Locations (10)

10032

Columbia University Medical Center, New York

19102

Drexel University College of Medicine, Philadelphia

33021

Sunrise Clinical Research, Hollywood

37920

NOCCR Knoxville, Knoxville

46202

Indiana University School of Medicine, Indianapolis

60007

Alexian Brothers Neuroscience Institute, Elk Grove Village

66214

MidAmerica NeuroScience Research Foundation, Lenexa

80304

Alpine Clinical Research Center, Boulder

92626

ATP Clinical Research, Costa Mesa

75390-9139

University of Texas Southwestern, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY